Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery.

Phillips-Bute B, Mathew JP, Blumenthal JA, Morris RW, Podgoreanu MV, Smith M, Stafford-Smith M, Grocott HP, Schwinn DA, Newman MF; Perioperative Genetics and Safety Outcomes Investigative Team..

Psychosom Med. 2008 Nov;70(9):953-9. doi: 10.1097/PSY.0b013e318187aee6.

2.

5-HTTLPR X stress in adolescent depression: moderation by MAOA and gender.

Priess-Groben HA, Hyde JS.

J Abnorm Child Psychol. 2013 Feb;41(2):281-94. doi: 10.1007/s10802-012-9672-1.

PMID:
22836288
3.

Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.

Foss-Nieradko B, Stepnowska M, Piotrowicz R.

Kardiol Pol. 2012;70(6):591-7. English, Polish.

4.

Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality.

Brummett BH, Krystal AD, Siegler IC, Kuhn C, Surwit RS, Züchner S, Ashley-Koch A, Barefoot JC, Williams RB.

Psychosom Med. 2007 Jun;69(5):396-401.

5.

The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.

Grochans E, Grzywacz A, Jurczak A, Samochowiec A, Karakiewicz B, Brodowska A, Starczewski A, Samochowiec J.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:125-30. doi: 10.1016/j.pnpbp.2013.05.007. Epub 2013 May 23.

PMID:
23707423
6.

Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer's disease and depression in the VITA study cohort: a 90-month longitudinal study.

Scholz CJ, Jungwirth S, Danielczyk W, Weber H, Wichart I, Tragl KH, Fischer P, Riederer P, Deckert J, Grünblatt E.

Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):184-91. doi: 10.1002/ajmg.b.32220. Epub 2014 Jan 17.

PMID:
24443391
7.

Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women.

Herman AI, Kaiss KM, Ma R, Philbeck JW, Hasan A, Dasti H, DePetrillo PB.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):74-8.

PMID:
15635592
8.

Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder.

Lung FW, Tzeng DS, Huang MF, Lee MB.

BMC Med Genet. 2011 May 24;12:74. doi: 10.1186/1471-2350-12-74.

9.

Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults.

Rawson KS, Dixon D, Nowotny P, Ricci WM, Binder EF, Rodebaugh TL, Wendleton L, Doré P, Lenze EJ.

PLoS One. 2015 Mar 17;10(3):e0120685. doi: 10.1371/journal.pone.0120685. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0126451.

10.

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

Mössner R, Henneberg A, Schmitt A, Syagailo YV, Grässle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP.

Mol Psychiatry. 2001 May;6(3):350-2.

11.

Attachment anxiety predicts depression and anxiety symptoms following coronary artery bypass graft surgery.

Kidd T, Poole L, Ronaldson A, Leigh E, Jahangiri M, Steptoe A.

Br J Health Psychol. 2016 Nov;21(4):796-811. doi: 10.1111/bjhp.12191.

12.
13.

[Association between serotonin transporter and monoamine oxidase A gene polymorphisms and depression].

Rojas R, Vicente B, Saldivia S, Melipillán R, Aedo G, Hormazabal N, Carroza A.

Rev Med Chil. 2015 Oct;143(10):1252-9. doi: 10.4067/S0034-98872015001000003. Spanish.

14.

Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study.

Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP.

Lancet. 2001 Nov 24;358(9295):1766-71.

PMID:
11734233
15.

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.

Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, Praschak-Rieder N, Zach J, de Zwaan M, Bondy B, Ackenheil M, Kasper S.

Arch Gen Psychiatry. 2002 Jul;59(7):613-20.

PMID:
12090814
16.

Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample.

Blom RM, Samuels JF, Riddle MA, Joseph Bienvenu O, Grados MA, Reti IM, Eaton WW, Liang KY, Nestadt G.

J Psychiatr Res. 2011 Sep;45(9):1153-9. doi: 10.1016/j.jpsychires.2011.03.003. Epub 2011 Mar 29.

17.

Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

Zhang H, Smith GN, Liu X, Holden JJ.

Physiol Genomics. 2010 Jun;42(1):85-92. doi: 10.1152/physiolgenomics.00220.2009. Epub 2010 Mar 23.

18.

Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study.

Ming QS, Zhang Y, Chai QL, Chen HY, Hou CJ, Wang MC, Wang YP, Cai L, Zhu XZ, Yi JY, Yao SQ.

BMC Psychiatry. 2013 May 17;13:142. doi: 10.1186/1471-244X-13-142.

19.

Association study of monoamine oxidase-A gene promoter polymorphism (MAOA-uVNTR) with self-reported anxiety and other psychopathological symptoms in a community sample of early adolescents.

Voltas N, Aparicio E, Arija V, Canals J.

J Anxiety Disord. 2015 Apr;31:65-72. doi: 10.1016/j.janxdis.2015.02.004. Epub 2015 Feb 21.

PMID:
25747527
20.

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF.

Arch Gen Psychiatry. 2004 Nov;61(11):1163-9.

PMID:
15520364

Supplemental Content

Support Center